Skip to main content

Blood Sugar

Twitter summary: Apple unveils smart watch with several sleek fitness apps – available early 2015 starting at $349 On September 9, Apple unveiled its first-ever smart...
At the 2014 American Diabetes Association conference, Maria Isabel Garcia, NP presented preliminary data from Project Dulce’s text-messaging based intervention, “Dulce...
Twitter summary: Lilly’s new basal #insulin Peglispro superior to Sanofi’s Lantus in A1c reduction, though some potential liver safety and hypo concerns On September 4,...
On July 15, Novartis announced a partnership with Google[x] to develop smart contact lenses that can non-invasively track blood glucose levels through tears and send the...
Twitter Summary: Abbott receives EU Approval to launch Freestyle Libre – updates from EASD on payment, device accuracy, design, and user experience On September 3,...
Getting to goal – the four biggest game-changers for improving my diabetes management.
Twitter: Livongo for Diabetes cloud-connected meter connects users to virtual care team, has algorithm-based feedback and built-in activity monitor Livongo Health...
We’ve been following the development of Lilly’s Trulicity (dulaglutide), a once-weekly GLP-1 receptor agonist , for almost two years now, so it was encouraging to hear...
How will a new “biosimilar” insulin compare to Sanofi’s Lantus?
Twitter summary: FDA approves Jardiance as third SGLT-2 inhibitor for #T2D, joins Invokana and Farxiga and potential future for #T1D On August 1, the FDA announced...
How much activity do you actually get? Why activity tracking is worth it, and perhaps needed more than ever.
Twitter Summary: Novo Nordisk’s Xultophy gets positive recommendation in Europe, full approval to hopefully come soon! On July 25, Novo Nordisk announced that the...
How this two-week trial looks to bring the Libre technology to health care.
What this dramatic movement in obesity therapy means for patients in Europe.
Twitter summary: UCSF launches SugarScience, an initiative on sugar’s dangerous health impacts. Visit SugarScience.org for more information A group of health scientists...
14-day sensor to replace glucose meters, but provide CGM-like info. Now available in Europe. When is it coming to the US? Read more for our full experience testing this...
Larger capacity reservoir will bring pump therapy to those with high insulin needs.
Our deep dive on a new therapy now available in Europe – the benefits, risks, and when it might come to the US.
Major A1c improvements, weight loss, and no injections!
First-ever SGLT-2/DPP-4 inhibitor drug, will this combination cut costs for patients?

Pages